5 Key Drugs Critical to Johnson & Johnson's Future
Johnson & Johnson (NYSE: JNJ) recently shared its third-quarter financial report card with investors, and by all measures, it deserves kudos. However, the stock market rewards investors based on future expectations, not past successes. If J&J is going to keep putting up impressive results, it's going to need to keep cashing in on its fastest-growing medicines.
Johnson & Johnson markets top consumer-goods brands like Band-Aid, and it's a big player in medical devices. But make no mistake -- this company's success or failure depends heavily on the performance of its pharmaceuticals business.
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
Johnson & Johnson Stock
€225.95
0.420%
With 57 Buy predictions and not a single Sell prediction Johnson & Johnson is an absolute favorite of our community.
At the moment Johnson & Johnson has reached the predicted target price of 228 €, with a current price of 225.95 €.
